chr16-1222012-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_012467.4(TPSG1):c.742C>T(p.Arg248Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000608 in 1,612,434 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_012467.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TPSG1 | NM_012467.4 | c.742C>T | p.Arg248Cys | missense_variant | 6/6 | ENST00000234798.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TPSG1 | ENST00000234798.5 | c.742C>T | p.Arg248Cys | missense_variant | 6/6 | 1 | NM_012467.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000369 AC: 56AN: 151892Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000888 AC: 22AN: 247678Hom.: 1 AF XY: 0.0000593 AC XY: 8AN XY: 134882
GnomAD4 exome AF: 0.0000294 AC: 43AN: 1460424Hom.: 0 Cov.: 77 AF XY: 0.0000248 AC XY: 18AN XY: 726494
GnomAD4 genome AF: 0.000362 AC: 55AN: 152010Hom.: 0 Cov.: 34 AF XY: 0.000363 AC XY: 27AN XY: 74296
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 03, 2022 | The c.742C>T (p.R248C) alteration is located in exon 6 (coding exon 6) of the TPSG1 gene. This alteration results from a C to T substitution at nucleotide position 742, causing the arginine (R) at amino acid position 248 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at